Pathway Financial Advisers’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,352
Closed -$461K 169
2024
Q4
$461K Sell
5,352
-717
-12% -$71.4K 0.15% 128
2024
Q3
$575K Sell
6,069
-173
-3% -$15.4K 0.26% 85
2024
Q2
$593K Buy
6,242
+302
+5% +$35.9K 0.21% 115
2024
Q1
$783K Buy
5,940
+3,925
+195% +$483K 0.28% 102
2023
Q4
$291K Sell
2,015
-79
-4% -$10.8K 0.11% 144
2023
Q3
$356K Buy
+2,094
New +$417K 0.15% 133
2023
Q1
$245K Buy
1,106
+11
+1% +$2.71K 0.1% 152
2022
Q4
$238K Buy
+1,095
New +$292K 0.1% 150

Other funds holding ALB

Pathway Financial Advisers's ALB Position: Q1 2025 in Review

Pathway Financial Advisers sold out of Albemarle (ALB) in Q1 2025, closing a stake of 5,352 shares — an estimated $461K sold.

Pathway Financial Advisers first reported a position in ALB in Q4 2022 and held it in 8 quarters. The position peaked at $783K in Q1 2024. 764 funds tracked by Wall St. Rank hold ALB as of Q1 2025.

  • Pathway Financial Advisers reported no remaining Albemarle position as of Q1 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 5,352 Albemarle shares in Q1 2025, an estimated $461K.
  • Pathway Financial Advisers first reported a position in Albemarle in Q4 2022 and held it in 8 quarters.
  • Pathway Financial Advisers's Albemarle position peaked at $783K in Q1 2024.
  • 764 funds tracked by Wall St. Rank held Albemarle as of Q1 2025.

Based on Pathway Financial Advisers's 13F filing for Q1 2025, filed 9 May 2025.